Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06520579 · ClinicalTrials.gov registry record · NA
Anterior Cervical Discectomy and Fusion (ACDF) - Behavioral Intervention
A NA study of Dysphagia, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06520579: Recruiting NA study of Dysphagia, sponsored by NYU Langone Health.
NCT06520579 is a NA study of Dysphagia that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 171-participant average among 35 other Dysphagia trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06520579, a NA study of Dysphagia, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will prospectively recruit and enroll patients undergoing primary Anterior Cervical Discectomy and Fusion (ACDF) surgeries at NYU Langone. Participants will undergo pre-operative and six-week post-operative swallowing assessment using videofluoroscopy (VFSS). Acoustic voice samples and Patient Reported Outcome Measures (PROMs) for swallowing and voice will also be collected. Beginning one-week before surgery participants will begin a behavioral health program that will be continued for six-weeks after surgery. The primary goal of this study will be to determine whether a preventative behavioral health program improves instrumental measures of swallowing and voice six-weeks after ACDF surgery. .
Primary Outcome
Outcome measure will be assessed using 2D lateral videofluoroscopic images will be used to measure pharyngeal constriction pre and post intervention
Conditions Studied
Interventions
- BEHAVIORAL Proactive pharyngeal-laryngeal Exercise Program
- DIETARY_SUPPLEMENT Premier Protein Clear ® High Protein
- BEHAVIORAL Hydration Counseling
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-10-15 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT06520579 shows while recruiting
NCT06520579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 171-participant average among 35 other Dysphagia trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Dysphagia appearing as the primary indexed condition, and to 3 interventions - of which Proactive pharyngeal-laryngeal Exercise Program is the first listed.
NCT06520579 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06520579 about?
NCT06520579 is a clinical study titled "Anterior Cervical Discectomy and Fusion (ACDF) - Behavioral Intervention". This study will prospectively recruit and enroll patients undergoing primary Anterior Cervical Discectomy and Fusion (ACDF) surgeries at NYU Langone. Participants will undergo pre-operative and six-week post-operative swallowing assessment using videofluoroscopy (VFSS). Acoustic voice samples and Pa...
What is the current status of trial NCT06520579?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-10-15. Estimated completion is 2026-09-01.
What conditions does trial NCT06520579 study?
This clinical trial studies the following conditions: Dysphagia.
What interventions are being tested in trial NCT06520579?
The interventions under investigation include: Proactive pharyngeal-laryngeal Exercise Program (BEHAVIORAL), Premier Protein Clear ® High Protein (DIETARY_SUPPLEMENT), Hydration Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT06520579?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06520579 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06520579's enrollment target sits among peer trials
50 23rd of 35 higher than 9 of 35 other Dysphagia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dysphagia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
RECRUITING · NA
-
Effect of Thickened Feeds on Swallow Physiology in Children With Dysphagia
RECRUITING · NA
-
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
RECRUITING · NA
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
RECRUITING · NA
-
External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing
RECRUITING · NA
-
The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United States
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI